Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xigris in Acute Ischemic Stroke
NCT00533546Phase 2Terminated
- Sponsor
- University of Rochester
- Start
- Sep 2007
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of drotrecogin alfa in ischemic stroke, sponsored by University of Rochester. Started Sep 2007; status: terminated.
02
Drugs
drotrecogin alfa
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00533546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533546.